Anxiety and depression comorbidities sleep disorders
Conditions
Interventions
Experimental group:Stellate ganglion block+pharmacological treatment
Control group:Conventional pharmacological treatment
Sponsors
Department of Anesthesiology, Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. ASA I-II, no gender limit, aged 18-75 years (including the threshold); 2. Confirm meeting any of the Diagnostic criteria for anxiety or depression in the Diagnostic and Statistical Manual of Mental Disorders-Five edition (DSM-V); 3. Confirm that you meet any of the diagnostic criteria for sleep disorders in the DSM-V.
Exclusion criteria
Exclusion criteria: 1. Patients during pregnancy or lactation; 2. Complicated with chronic systemic diseases, including but not limited to: serious cardiopulmonary diseases, neuropsychiatric diseases, liver and kidney insufficiency, neck surgery; 3. Severe coagulation dysfunction; 4. Puncture site infection and skin damage; 5. History of drug abuse or alcoholism; 6. Diabetic patients with unsatisfactory blood glucose control (fasting blood glucose >=11.1mmol/L).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of improvement in patients with sleep disorders after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| The degree of improvement in patients' anxiety symptoms after treatment;The degree of improvement in patients' depressive symptoms after treatment; | — |
Countries
China
Contacts
Public ContactDai Yue'e
Department of Anesthesiology, Sichuan Provincial People's Hospital
Outcome results
None listed